Molecular basis for protein s hereditary deficiency: Genetic defects observed in 118 patients with type I and type IIa deficiencies

Journal of Laboratory and Clinical Medicine

Volumn 128, Issue 2, 1996, Pages 218-227

  Borgel, Delphine ^a   Duchemin, Jérôme ^b   Alhenc Gelas, Martine ^b   Matheron, Catherine ^b   Aiach, Martine ^b   Gandrille, Sophie ^b  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030205254     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90015-3     Document Type: Article

References (64)

1. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965;13:516-30.
2. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bettina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993;342:1503-7.
3. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994;330: 517-22.
4. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981;68:1370-3.
5. Comp PC, Esmon CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984;311:1525-8.
6. Schwartz H, Fischer M, Hopmeier P, Batard MA, Griffin HH. Familial protein S deficiency is associated with recurrent thrombosis. Blood 1984;64:1297-300.
7. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation F V associated with resistance to activated protein C. Nature 1994;369:64-7.
8. Reitsma PH, Bernardi F, Doig RG, et al. Protein C deficiency: a database of mutations. 1995 update. On behalf of the subcommittee on plasma coagulation inhibitors of the scientific and standardization committee of the ISTH. Thromb Haemost 1995;73:876-89.
9. Ploos van Amstel HK, Huisman MV, Reitsma PH, ten Gate JW, Bertina RM. Partial protein S gene deletion in a family with hereditary thrombophilia. Blood 1989;73:479-83.
10. Schmidel DK, Nelson RM, Broxson EH Jr, Comp PC, Marlar RA, Long GL. A 5.3-kb deletion including exon XIII of the protein S gene occurs in two protein S-deficient families. Blood 1991;77:551-9.
11. Reitsma PH, Ploos van Amstel HK, Bertina RM. Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I. J Clin Invest 1994;93:486-92.
12. Borgel D, Gandrille S, Gouault-Heilmann M, Aiach M. First frameshift mutation in the active protein S gene associated with a quantitative hereditary deficiency. Blood Coagul Fibrinolysis 1994;5:593-600.
13. Gomez E, Ledford MR, Pegelow CH, Reitsma PH, Bertina RM. Homozygous protein S deficiency due to a one base pairdeletion that leads to a stop codon in exon III of the protein S gene. Thromb Haemost 1994;71:723-6.
14. Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzuki K. Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth F-like domains of protein S. Blood 1994;83:683-90.
15. Gomez E, Poort SR, Bertina RM, Reitsma PH. Identification of eight point mutations in protein S deficiency type I. Analysis of 15 pedigrees. Thromb Haemost 1995;73:750-5.
16. Gandrille S, Borgel D, Eschwege-Gufflet V, et al. Identification of 15 different candidate causal point mutations and 3 polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active gene. Blood 1995;85:130-8.
17. Yamazaki T, Motohiro H, Akira K, et al. A quantitative protein S deficiency associated with a novel nonsense mutation and markedly reduced levels of mutated mRNA. Thromb Haemost 1995;74:590-5.
18. Formstone C, Wacey A, Berg L, et al. Detection and characterization of seven novel protein S (PROS) gene. Lesions: evaluation of reverse transcript-polymerase chain reaction as a mutation screening strategy. Blood 1995;86: 2632-41.
19. Mustafa S, Pabinger I, Mannhalter C. Protein S deficiency type I: identification of point mutations in 9 of 10 families. Blood 1995;86:3444-51.
20. Duchemin J, Borg JY, Borgel D, et al. Five novel mutations of the protein S active gene (PROS1) in 8 Norman families. Thromb Haemost 1996;75:437-44.
21. Esmon CT. Protein S and protein C. Biochemistry, physiology, and clinical manifestation of deficiencies. Trends Cardiovasc Med 1992;2:214-9.
22. Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of protein S to F Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993;268:2872-7.
23. Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin JH. Protein S binds to and inhibits F Xa. Proc Natl Acad Sci USA 1994;91:2728-32.
24. Dahlbäck B. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991;66:49-61.
25. Griffin JH, Gruber A, Fernandez JA. Reevaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin. Blood 1992;79: 3203-11.
26. Malm J, Laurell M, Dahlbäck B. Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception. Br J Haematol 1988;68:437-43.
27. D'Angelo A, Vigano-D'Angelo S, Esmon CT, Comp PC. Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J Clin Invest 1988;81: 1445-54.
28. Henkens C, Bom V, van der Schaaf W, et al. Plasma levels of protein S, protein C, and F X: effect of sex, hormonal state and age. Thromb Haemost 1995;74:1271-5.
29. Comp PC, Doray D, Patton D, Esmon CT. An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 1985;67:504-8.
30. Comp PC. Laboratory evaluation of protein S status. Semin Thromb Hemost 1990;16:177-81.
31. Watkins P, Eddy R, Fukushima Y, et al. The gene for protein S maps near the centomer of human chromosome 3. Blood 1988;71:238-41.
32. Edenbrandt CM, Lundwall A, Wydro R, Stenflo J. Molecular analysis of the gene for vitamin K dependent protein S and its pseudogene. Cloning and partial gene organization. Biochemistry 1990;29:7861-8.
33. Ploos van Amstel HK, Reitsma PH, van der Logt PE, Bertina RM. Intron-exon organization of the active human protein S gene PSa and its pseudogene PSb: duplication and silencing during primate evolution. Biochemistry 1990; 29:7853-61.
34. Schmidel DK, Tatro AV, Tomczak JA, Long GL. Organization of the human protein S genes. Biochemistry 1990;29: 7845-52.
35. Gandrille S, Goossens M, Aiach M. Scanning method to establish the molecular basis of protein C deficiencies. Hum Mutat 1994;4:20-30.
36. Gandrille S, Greengard J, Alhenc-Gelas M, et al. Incidence of activated protein C resistance due to the Arg 506 Gln mutation in F V in 113 unrelated symptomatic protein C deficient patients. Blood 1995;86:219-24.
37. Gandrille S, Alhenc-Gelas M, Aiach M. A rapid screening method for the F V Arg 506 Gln mutation. Blood Coagul Fibrinolysis 1995;6:245-8.
38. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74:5463-7.
39. Bertina RM, Ploos van Amstel HK, van Wijngaarden A, et al. Heerlen polymorphism of protein S, an immunologic polymorphism due to dimorphism of residue 460. Blood 1990;76: 538-48.
40. Duchemin J, Gandrille S, Borgel D, et al. The Ser 460 to Pro substitution of the protein S a (PROS1) gene is a frequent mutation associated with free protein S (type IIa) deficiency. Blood 1995;86:3436-43.
41. Pabinger I, Brücker S, Kyrie PA, Schneider B, Korninger HC, Niessner H, et al. Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for ratio nal patient screening. Blood Coagul Fibrinolysis 1992;3: 547-53.
42. Lerman LS, Silverstein K. Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. In: Methods in enzymology. New York: Academic Press, 1987:482-501.
43. Higuchi M, Antonarakis SE, Kasch L, et al. Molecular characterization of mild-to-moderate hemophilia A: detection of the mutation in 25 of 29 patients by denaturing gradient gel electrophoresis. Proc Natl Acad Sci USA 1991;88:8307-11.
44. Attree O, Vidaud D, Vidaud M, Amselem S, Lavergne JM, Goossens M. Mutations in the catalytic domain of human coagulation F IX: rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior. Genomics 1989;4:266-72.
45. Ghanem N, Girodon E, Vidaud M, et al. A comprehensive scanning method for rapid detection of β-globin gene mutations and polymorphisms. Hum Mutat 1992;1:229-39.
46. Top B, Van Der Zee A, Havekes LM, Van't Hooft FM, Frants RR. Identification of a splice-site mutation in the low density lipoprotein receptor gene by denaturing gradient gel electrophoresis. Hum Genet 1994;91:480-4.
47. Fanen P, Ghanem N, Vidaud M, et al. Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions. Genomics 1992;13:770-6.
48. Tartary M, Vidaud D, Piao Y, et al. Detection of a molecular defect in 40 of 44 patients with haemophilia B by PCR and denaturing gradient gel electrophoresis. Br J Haematol 1993; 84:662-9.
49. Higuchi M, Kazazian HH, Kasch L, et al. Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the F VIII gene. Proc Natl Acad Sci USA 1991;88: 7405-9.
50. Lakich D, Kazazian HH, Antonarakis SE, Gitschier J. Inversions disrupting the F VIII gene are a common cause of severe haemophilia A. Nat Genet 1993;5:236-41.
51. Higashi Y, Tanae A, Inoue H, Hiromasa T, Fujii-Kuriyama Y. Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products. Proc Natl Acad Sci USA 1988;85: 7486-90.
52. Lundwall A, Dackowski W, Cohen E, et al. Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation. Proc Natl Acad Sci USA 1986;83:6716-20.
53. Hoskins JA, Norman DK, Beckmann RJ, Long GL. Cloning and characterization of human liver cDNA encoding a protein S precursor. Proc Natl Acad Sci USA 1987;84:349-53.
54. Chu MD, Sun J, Bird P. Cloning and sequencing of a cDNA encoding the murine vitamin K-dependent protein S. Biochim Biophys Acta 1994;1217:325-8.
55. Dahlbäck B, Lundwall A, Stenflo J. Primary structure of bovine vitamin K-dependent protein S. Proc Natl Acad Sci USA 1986;83:4199-203.
56. He X, Dahlbäck B. Molecular cloning, expression and functional characterization of rabbit anticoagulant vitamin K-dependent protein S. Eur J Biochem 1993;217:857-65.
57. Zöller B, Garcia de Frutos P, Dahlbäck B. Evaluation of the relation between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood 1995;85:3524-31.
58. de Frutos PG, Alim RIM, Härdig Y, Zöller B, Dahlbäck B. Differential regulation of a and b chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood 1994;84: 815-22.
59. Boerger LM, Morris PC, Thurnau GR, Esmon CT, Comp PC. Oral contraceptives and gender affect protein S status. Blood 1987;69:692-4.
60. Gari M, Kalkon L, Urrutia T, Vallvé C, Borrell M, Fontcuberta J. The influence of low protein S plasma levels in young women, on the definition of normal range. Thromb Res 1995;73:149-52.
61. Zöller B, Svensson PJ, He X, Dahlbäck B. Identification of the same F V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994;94:2521-4.
62. Zöller B, Berntsdotter A, Garcia de Frutos P, Dahlbäck B. Resistance to actived protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995;85: 3518-23.
63. Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG. Inherited predisposition to thrombosis. Cell 1993;72: 477-80.
64. Dahlbäck B. Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. J Clin Invest 1994;94:923-7.